CYTOMED THERAPEUTICS LTD (GDTC) Stock Balance Sheet
NASDAQ:GDTC - Nasdaq - SGXZ17669631 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.47M | 9.00M | 1.58M | 2.51M | 890.00K | |||
| Receivables | 48.84K | 204.75K | 60.00K | 10.00K | 10.00K | |||
| Inventories | N/A | N/A | N/A | N/A | 240.00K | |||
| Other Current Assets | 1.19M | 896.81K | 860.00K | 770.00K | 330.00K | |||
| Total Current Assets | 7.71M | 10.10M | 2.49M | 3.28M | 1.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.48M | 2.06M | 2.47M | 2.50M | 2.30M | |||
| Investments And Advances | 211.01K | 195.07K | 240.00K | 270.00K | N/A | |||
| Goodwill | 360.00 | 360.00 | 0.00 | 0.00 | 0.00 | |||
| Intangibles | 10.66K | 12.06K | 20.00K | 30.00K | 40.00K | |||
| Total Non-Current Assets | 3.20M | 2.27M | 2.74M | 2.80M | 2.35M | |||
| TOTAL ASSETS | 10.91M | 12.37M | 5.23M | 6.08M | 3.82M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 3.70M | 2.66M | 2.32M | |||
| Current Portion Of LT Debt. | 37.39K | 40.25K | 40.00K | 40.00K | 40.00K | |||
| Accrued Expenses | 241.57K | 446.63K | 240.00K | 150.00K | 290.00K | |||
| Accounts Payable | 44.83K | 24.62K | 10.00K | 50.00K | 20.00K | |||
| Other Current Liabilities | 34.12K | 205.44K | 170.00K | 40.00K | 50.00K | |||
| Total Current Liabilities | 357.92K | 716.94K | 4.17M | 2.94M | 2.73M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 390.90K | 407.77K | 480.00K | 550.00K | 610.00K | |||
| Total Non-Current Liabilities | 389.79K | 406.82K | 470.00K | 550.00K | 610.00K | |||
| TOTAL LIABILITIES | 747.71K | 1.12M | 4.64M | 3.49M | 3.34M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -13.42M | -12.26M | -8.20M | -5.07M | -3.02M | |||
| Additional Paid In Capital | N/A | N/A | 0.00 | 1.14M | N/A | |||
| Minority Interest | -1.10K | -960.00 | 0.00 | 0.00 | 0.00 | |||
| Common Shares | 23.79M | 23.72M | 8.91M | 6.55M | 3.50M | |||
| Other Shareholders' Equity | -212.01K | -217.40K | -130.00K | -30.00K | -10.00K | |||
| Shares Outstanding | 11.53M | 11.53M | 11.53M | 10.94M | 10.94M | |||
| Tangible Book Value per Share | 0.88 | 0.97 | 0.05 | 0.23 | 0.04 | |||
| Total Shareholders' Equity | 10.16M | 11.25M | 590.00K | 2.59M | 480.00K | |||
| TOTAL LIABILITIES AND EQUITY | 10.91M | 12.37M | 5.23M | 6.08M | 3.82M | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.04 | 7.08 | 1.24 | 6.10 | |||
| Current Ratio | 21.53 | 14.08 | 0.60 | 1.12 | 0.54 | |||
| Return On Assets (ROA) | -28.08% | -33.41% | -59.85% | -33.72% | -50.79% | |||
| Return On Equity (ROE) | -30.14% | -36.75% | -530.51% | -79.15% | -404.17% | |||
All data in SGD , ROIC based on taxRate of 0.21